source
- Biotech fundraising tracker reports $70M Series C for Ratio Therapeutics and $130M Series B for Crystalys TherapeuticsThe Fierce Biotech Fundraising Tracker continues to log only large venture capital rounds, focusing on deals of $50 million or more. Ratio Therapeutics secured a $70 million Series C, backed by in…